中科微点-全球专利检索

  1. Login
  2. Sign Up
Invention Grant
US09085582B2 Benzotriazolodiazepine compounds inhibitors of bromodomains 有权
苯并三氮唑并嘧啶化合物溴结构域抑制剂

  • Patent Title: Benzotriazolodiazepine compounds inhibitors of bromodomains
  • Patent Title (中): 苯并三氮唑并嘧啶化合物溴结构域抑制剂
  • Application No.: US13702177
    Application Date: 2011-06-20
  • Publication No.: US09085582B2
    Publication Date: 2015-07-21
  • Inventor: James Matthew Bailey
  • Applicant: James Matthew Bailey
  • Applicant Address: US DE Wilmington
  • Assignee: GlaxoSmithKline LLC
  • Current Assignee: GlaxoSmithKline LLC
  • Current Assignee Address: US DE Wilmington
  • Agent Robert H. Brink
  • Priority: GB1010514.6 20100622; GB1106801.2 20110421
  • International Application: PCT/EP2011/060179 WO 20110620
  • International Announcement: WO2011/161031 WO 20111229
  • Main IPC: A61K31/5517
  • IPC: A61K31/5517 ;  C07D487/04 ;  A61K45/06
Benzotriazolodiazepine compounds inhibitors of bromodomains
Abstract:
Benzodiazepine compounds, pharmaceutical compositions containing such compounds and to their use in therapy.
Abstract(Chinese):

苯并二氮杂类化合物，含有这些化合物的药物组合物及其在治疗中的用途。

Public/Granted literature
Information query
Espacenet
Patent Agency Ranking
0/0